Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aptuit
CRO
Evotec to fill pre-IND service gap with $300M Aptuit buy
German CRO Evotec is acquiring U.S. counterpart Aptuit in a $300 million deal.
Angus Liu
Aug 1, 2017 10:00am
Regulus taps Aptuit to help advance pipeline
Jun 14, 2017 11:37am
Chiesi renews respiratory drug discovery deal with Charles River
Mar 13, 2017 11:16am
Bioversys, Aptuit team up to find novel antibiotic targets
Mar 7, 2017 8:58am
Aptuit teams up with respiratory R&D expert Chiesi on IPF drug discovery
Jan 4, 2017 4:11pm
Aptuit buys Kuecept in second straight deal
May 11, 2016 2:43pm
